Artificial hips and hip resurfacing are recommended as possible treatments for people with end‑stage arthritis of the hip.
Only an artificial hip or hip resurfacing with a replacement rate of less than 1 in 20 at 10 years should be used.
What does this mean for me?
If you have end‑stage hip arthritis, and your doctor thinks that an artificial hip or hip resurfacing is the right treatment, you should be able to have the treatment on the NHS.
This guidance updates and replaces NICE technology appraisal guidance 2 issued in April 2000 and NICE technology appraisal guidance 44 in June 2002.
The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the guidance to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.